| 产品详情 |
| Edit |   |
|---|
| Product Name | SKOV-3/Luc Cell Line |
|---|
| Description | • These cell lines stably express one or more reporter molecules.The human ovary cancer cell line SKOV-3 was derived from the ascitic fluid of a 64 year old Caucasian female with an ovarian tumor in 1973. SK-OV-3 cells are resistant to tumor necrosis factor and to several cytotoxic drugs including diphtheria toxin, cis- platinum and adriamycin. With epithelial-like morphology, SKOV-3 has abundant activity in both the Boyden chamber chemotaxis and invasion assay. The SKOV-3 cell |
|---|
| Size | 1 Vial |
|---|
| Concentration | 1 mL, 1 x 10^6 cells/mL in 70% DMEM, 20% FBS, 10% DMSO |
|---|
| Applications | n/a |
|---|
| Other Names | [SKOV-3/Luc Cell Line] |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | MBS168774 |
|---|
| Price | |
|---|
| Order / More Info | SKOV-3/Luc Cell Line from MYBIOSOURCE INC. |
|---|
| Product Specific References | 1. Pham, E. et al. (2015). Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer. Clin Cancer Res. 21:808-818. 2. Batchu, R. B. et al. (2014). Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector. Vaccine. 32:938-943. |
|---|
| 产品资料 |
|
|